| 000 | 01479nam a2200397 a 4500 | ||
|---|---|---|---|
| 005 | 20250918172217.0 | ||
| 008 | 130111 2013 xxka 001 0 eng | ||
| 020 |
_a9781405195751 _cRM436.49 (PPUKM) |
||
| 020 |
_a9781405195751 _cRM454.62 (PPUKMPRA) |
||
| 039 | 9 |
_a201407031148 _bzainol _c201403031655 _dsue _c201402211547 _dsue _c201402211140 _dsue _y01-11-2013 _zbalqis |
|
| 040 | _dUKM | ||
| 090 | _aWK820.L665m 2013 9HUKM | ||
| 090 |
_aWK820 _b.L665m 2013 9HUKM |
||
| 090 |
_aWK820 _b.L665m 2013 9HUKMPRA |
||
| 090 |
_aWK820 _b.L665m 2013 9 |
||
| 100 | 1 | _aLevine, T. Barry. | |
| 245 | 1 | 0 |
_aMetabolic syndrome and cardiovascular disease / _cT. Barry Levine, Arlene B. Levine. |
| 250 | _a2nd ed. | ||
| 260 |
_aChichester, West Sussex : _bWiley-Blackwell, _c2013. |
||
| 300 |
_axiii, 498 p. : _c28 cm. |
||
| 650 | 2 | _aMetabolic Syndrome X. | |
| 650 | 2 | _aRisk factors. | |
| 650 | 2 |
_aCardiovascular Diseases _xetiology. |
|
| 650 | 2 |
_aCardiovascular Diseases _xprevention & control. |
|
| 700 | 1 | _aLevine, Arlene B. | |
| 907 |
_a.b15558393 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWK820.L665m 2013 9HUKM |
||
| 914 | _avtls003521706 | ||
| 990 | _aNHR/azriq/shafiq/wafi/sue | ||
| 991 | _aJabatan Perubatan, PPUKM | ||
| 991 | _aJabatan Farmakologi, Pra Klinikal PPUKM | ||
| 991 | _aJabatan Farmakologi, KKL | ||
| 998 |
_ad _ap _a(2)h _b2013-11-01 _cm _da _feng _gxxk _y0 _z.b15558393 |
||
| 999 |
_c538782 _d538782 |
||